A detailed history of Autus Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Autus Asset Management, LLC holds 99,675 shares of ABT stock, worth $11.4 Million. This represents 1.97% of its overall portfolio holdings.

Number of Shares
99,675
Previous 101,392 1.69%
Holding current value
$11.4 Million
Previous $9.81 Million 11.56%
% of portfolio
1.97%
Previous 1.88%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$95.06 - $111.52 $163,218 - $191,479
-1,717 Reduced 1.69%
99,675 $0
Q3 2022

Oct 13, 2022

SELL
$96.76 - $112.03 $95,598 - $110,685
-988 Reduced 0.97%
101,392 $9.81 Million
Q2 2022

Jul 22, 2022

SELL
$102.07 - $123.37 $80,329 - $97,092
-787 Reduced 0.76%
102,380 $11.1 Million
Q1 2022

Apr 13, 2022

SELL
$114.02 - $139.04 $3.51 Million - $4.29 Million
-30,822 Reduced 23.0%
103,167 $12.2 Million
Q4 2021

Jan 14, 2022

SELL
$115.53 - $141.46 $155,734 - $190,688
-1,348 Reduced 1.0%
133,989 $18.9 Million
Q3 2021

Oct 18, 2021

BUY
$116.66 - $129.06 $12,132 - $13,422
104 Added 0.08%
135,337 $16 Million
Q2 2021

Jul 16, 2021

SELL
$105.79 - $124.53 $86,218 - $101,491
-815 Reduced 0.6%
135,233 $15.7 Million
Q1 2021

Apr 14, 2021

BUY
$108.84 - $128.23 $341,975 - $402,898
3,142 Added 2.36%
136,048 $16.3 Million
Q4 2020

Jan 19, 2021

SELL
$105.0 - $114.42 $1.48 Million - $1.61 Million
-14,104 Reduced 9.59%
132,906 $14.6 Million
Q3 2020

Oct 13, 2020

SELL
$91.64 - $111.29 $72,120 - $87,585
-787 Reduced 0.53%
147,010 $16 Million
Q2 2020

Jul 16, 2020

SELL
$76.57 - $98.0 $43,798 - $56,056
-572 Reduced 0.39%
147,797 $13.5 Million
Q1 2020

Apr 16, 2020

BUY
$62.82 - $91.86 $245,186 - $358,529
3,903 Added 2.7%
148,369 $11.7 Million
Q4 2019

Jan 24, 2020

BUY
$78.51 - $87.4 $73,799 - $82,156
940 Added 0.65%
144,466 $12.5 Million
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $327,687 - $355,314
-4,004 Reduced 2.71%
143,526 $12 Million
Q2 2019

Jul 15, 2019

BUY
$72.88 - $85.0 $14,138 - $16,490
194 Added 0.13%
147,530 $12.4 Million
Q1 2019

Apr 16, 2019

BUY
$66.22 - $80.06 $1.36 Million - $1.64 Million
20,508 Added 16.17%
147,336 $11.8 Million
Q4 2018

Feb 11, 2019

SELL
$65.56 - $74.27 $171,046 - $193,770
-2,609 Reduced 2.02%
126,828 $9.17 Million
Q3 2018

Oct 26, 2018

BUY
$60.81 - $73.36 $141,322 - $170,488
2,324 Added 1.83%
129,437 $9.5 Million
Q2 2018

Aug 03, 2018

BUY
$57.57 - $63.54 $231,143 - $255,113
4,015 Added 3.26%
127,113 $7.75 Million
Q1 2018

Apr 24, 2018

BUY
$56.27 - $63.62 $19,244 - $21,758
342 Added 0.28%
123,098 $7.38 Million
Q4 2017

Feb 01, 2018

SELL
$53.68 - $57.47 $26,034 - $27,872
-485 Reduced 0.39%
122,756 $7.01 Million
Q3 2017

Nov 08, 2017

SELL
$48.06 - $53.64 $43,590 - $48,651
-907 Reduced 0.73%
123,241 $6.58 Million
Q2 2017

Aug 09, 2017

BUY
N/A
124,148
124,148 $6.04 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Autus Asset Management, LLC Portfolio

Follow Autus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Autus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Autus Asset Management, LLC with notifications on news.